Article Text

Download PDFPDF
Povidone-iodine pleurodesis for congenital chylothorax of the newborn
  1. Bernhard Resch1,2,
  2. Thomas Freidl2,
  3. Friedrich Reiterer2
  1. 1 Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria
  2. 2 Division of Neonatology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria
  1. Correspondence to Dr Bernhard Resch, Klinische Abteilung für Neonatologie, Univ. Klinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Österreich, Auenbruggerplatz 34/2, Graz 8036, Austria; bernhard.resch{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Chemical pleurodesis with povidone-iodine (PVI) in neonates has been first described by Brissaud et al 1 in four cases of congenital chylothorax (CCT). Since this report, a few more cases of PVI pleurodesis have been reported in the literature.2–5 Adding our own experience of a fatal case of CCT with histologically proven pulmonary lymphangiectasis, we aimed to summarise the current evidence for PVI pleurodesis in case of CCT by means of a literature review.

We report the case of a preterm infant (29 weeks’ gestational age, birth weight 1530 g) born by caesarean section (antenatal steroids were given 17 days before birth; Apgar scores at 1/5/10 min were 4/7/7, respectively) with bilateral pleural effusions requiring chest …

View Full Text


  • Contributors BR and FR conceptualised and designed the study, screened the literature, identified using the search protocol, abstracted data from selected studies, drafted the initial manuscript and approved the final manuscript as submitted. TF created the literature search protocol, performed the electronic database searches and critically reviewed the manuscript and approved the final manuscript as submitted.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.